Neostigmine Overview Categories 1 Drugs used in anesthesia1.4 Muscle relaxants and cholinesterase inhibitors 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Neostigmine Manufacturers of Neostigmine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Neostigmine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.02 mg/ kg0.02 (0.02)As recommended.IMFor diagnosis of myasthenia gravis0.5 to 2.5 mg1.5 (1.5)As recommended.IV, IM, SCAdditional doses depend upon the patient response. Max. 10mg/day75 to 300 mg190 (187.5)4 hourlyPOMax. 180mg/day500 ug500 (500)4 hourlyPO,S/C,IMFor paralytic ileus & postperative urinary retention. Paedriatic Dosage (20kg) 50 to 0 ug/kg25 (25)As recommended.Intra VenousTo severe neuromuscular blockade.200 to 0 mg/kg100 (100)6 hourlyOralFor Myasthenia grains. Neonatal Dosage (3kg) 50 ug/kg50 (50)As recommended.IntravenousAs required0.5 to 1 mg/kg0.75 (0.75)6 hourlyOralFor all ages High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Neostigmine Back to top Manufacturers of Neostigmine in Pakistan Akhai Brookes Caraway Elite Fassgen Global Goodman Haji Indus Mass Neutro Siza Back to top Previous Drug Generic - Next Drug Generic
Neostigmine Overview Categories 1 Drugs used in anesthesia1.4 Muscle relaxants and cholinesterase inhibitors 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Neostigmine Manufacturers of Neostigmine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Neostigmine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.02 mg/ kg0.02 (0.02)As recommended.IMFor diagnosis of myasthenia gravis0.5 to 2.5 mg1.5 (1.5)As recommended.IV, IM, SCAdditional doses depend upon the patient response. Max. 10mg/day75 to 300 mg190 (187.5)4 hourlyPOMax. 180mg/day500 ug500 (500)4 hourlyPO,S/C,IMFor paralytic ileus & postperative urinary retention. Paedriatic Dosage (20kg) 50 to 0 ug/kg25 (25)As recommended.Intra VenousTo severe neuromuscular blockade.200 to 0 mg/kg100 (100)6 hourlyOralFor Myasthenia grains. Neonatal Dosage (3kg) 50 ug/kg50 (50)As recommended.IntravenousAs required0.5 to 1 mg/kg0.75 (0.75)6 hourlyOralFor all ages High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Neostigmine Back to top Manufacturers of Neostigmine in Pakistan Akhai Brookes Caraway Elite Fassgen Global Goodman Haji Indus Mass Neutro Siza Back to top Previous Drug Generic - Next Drug Generic